Myeloproliferative Neoplasms

Top Story

AACR: Advances in cancer research, medical funding allow for ‘phenomenal’ progress

AACR: Advances in cancer research, medical funding allow for ‘phenomenal’ progress
October 17, 2017

Oncology leaders who participated in an American Association for Cancer Research webinar this afternoon highlighted several advances in cancer research and emphasized the importance of robust medical research funding.

Webinar participants also provided updates on the seventh annual AACR Cancer Progress Report, released last month. The report — titled “Harnessing Research Discoveries to Save Lives” — provided a snapshot of cancer progress this year, and also offered recommendations to increase public understanding and advocate for increased federal funding.

NIH collaboration aims to identify, validate immunotherapy biomarkers

October 13, 2017
NIH launched the Partnership for Accelerating Cancer Therapies, a 5-year public-private research collaboration. The $215 million effort is part of the national cancer…
Meeting News

HemOnc Today New York to highlight advances in immunotherapy, targeted treatments

October 11, 2017
HemOnc Today is pleased to announce plans for a 3-day CME meeting designed to offer expert perspectives and practical insights into the use of immunotherapy and…
In the Journals Plus

Pretransplant vitamin D deficiency may heighten relapse risk in myeloid malignancies

October 10, 2017
A deficiency in vitamin D prior to allogeneic hematopoietic stem cell transplantation increased risk for relapse among patients with myeloid malignancies, according to a…
More Headlines »
CME

Diagnostic and Therapeutic Challenges in Von Willebrand Disease

This activity is supported by an educational grant from Shire.

With the significant variability in the subtypes and clinical manifestations of von Willebrand disease (VWD), diagnosis…
More »
Video

VIDEO: Toxicities related to immune therapies ‘unpredictable’ but ‘manageable’

June 23, 2016
More »
Resource Centers
European Society for Medical Oncology Congress

European Society for Medical Oncology Congress

CME

Hot Topics in Metastatic Breast Cancer Management: Clinical Advances with CDK4/6 Inhibitors

This activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.

While the mortality rates for advanced or metastatic breast cancer (MBC) have steadily decreased, in part due to…
More »
Advertisement
Advertisement